Moreover, the number of TRAP-positive MNCs generated from PBMs treated with M-CSF, RANKL and TGFβ1 in healthy controls were significantly lower than those in patients with RA (p = 0.022, Figure 1e). The gene discussed is ACP5; the disease is rheumatoid arthritis.